Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Hypoparathyroidism peptide trials
5 selected ClinicalTrials.gov records carrying the official condition label Hypoparathyroidism. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
5 selected records.
2 profiles.
2022–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 71 selected PubMed records and 8 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hypoparathyroidism unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT07081997
PeptideScanner retained ClinicalTrials.gov record NCT07081997 at 2026-11-15T21:57:58.320Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was palopegteriparatide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- November 5, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07264634
PeptideScanner retained ClinicalTrials.gov record NCT07264634 at 2026-11-15T21:57:58.320Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was palopegteriparatide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- August 7, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07345494
PeptideScanner retained ClinicalTrials.gov record NCT07345494 at 2026-11-15T21:57:58.320Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was palopegteriparatide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 2, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Palopegteriparatide · 2026-11-05
ClinicalTrials.gov record NCT07081997
Recruiting at the retained observation.
Open attributed record →Palopegteriparatide · 2026-08-07
ClinicalTrials.gov record NCT07264634
Recruiting at the retained observation.
Open attributed record →Palopegteriparatide · 2026-07-28
ClinicalTrials.gov record NCT07706764
Recruiting at the retained observation.
Open attributed record →Palopegteriparatide · 2026-03-02
ClinicalTrials.gov record NCT07345494
Recruiting at the retained observation.
Open attributed record →Teriparatide · 2022-11-10
ClinicalTrials.gov record NCT04750460
Completed at the retained observation.
Open attributed record →